Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Phoenix, Arizona, United States
Recruiting - Sarah Cannon Research Institute (scri) - Healthone Location
Denver, Colorado, United States
Recruiting - Rocky Mountain Cancer Centers, Llp - Oncology
Lone Tree, Colorado, United States
Recruiting - Mayo Clinic
Jacksonville, Florida, United States
Recruiting - Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, Florida, United States
Recruiting - Local Institution - 124
Chicago, Illinois, United States
Withdrawn - Dana-Farber Cancer Institute
Brookline, Massachusetts, United States
Recruiting - Cancer and Hematology Centers of Western Michigan
Norton Shores, Michigan, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Recruiting - Local Institution - 129
Mineola, New York, United States
Not, yet, recruiting - David H Koch, Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - New York Cancer and Blood Specialists - Oncology
Port Jefferson Station, New York, United States
Recruiting - New York Cancer and Blood Specialists - Oncology
Port Jefferson Station, New York, United States
Recruiting - University of North Carolina
Chapel Hill, North Carolina, United States
Recruiting - University of North Carolina - Gastroenterology and Hepatology
Chapel Hill, North Carolina, United States
Recruiting - Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
Recruiting - Ut Southwestern
Dallas, Texas, United States
Recruiting - Texas Oncology - Dfw
Fort Worth, Texas, United States
Recruiting - Mdacc
Houston, Texas, United States
Recruiting - South Texas Accelerated Research Therapeutics
San Antonio, Texas, United States
Recruiting - Texas Oncology, P.A. - Oncology
Tyler, Texas, United States
Recruiting - Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Recruiting - Local Institution - 134
Seattle, Washington, United States
Withdrawn - Local Institution - 108
Milwaukee, Wisconsin, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jun 2022
- Primary completion
- 10 Dec 2027
- Completion
- 10 Dec 2027
- Last update posted
- 5 Dec 2025
- Registered enrollment
- 336
- Registry id
- NCT05245500
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.